Viewing Study NCT03388632

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:32 PM
Ignite Modification Date: 2026-02-10 @ 1:16 AM
Study NCT ID: NCT03388632
Status: COMPLETED
Last Update Posted: 2025-12-18
First Post: 2017-12-30
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Recombinant Interleukin-15 in Combination With Checkpoint Inhibitors Nivolumab and Ipilimumab in People With Refractory Cancers
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Solid Tumors View
None Treatment-Refractory Cancers View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Immunotherapy View
None T Cells View
None Checkpoint Inhibitor View
None IL-15 View
None Combination Therapy View